Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy

Lasers in Surgery and Medicine

Volumn 40, Issue 8, 2008, Pages 535-542

  Hirschberg, Henry ^a,b   Uzal, Francisco A ^c   Chighvinadze, David ^b   Zhang, Michelle J ^b   Peng, Qian ^d   Madsen, Steen J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NEVADA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Brain edema; Fischer rat; Fluence; Fluence rate; Magnetic resonance imaging; Malignant glioma

Indexed keywords

AMINOLEVULINIC ACID; GADOLINIUM; GADOLINIUM PENTETATE; HEMATOPORPHYRIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; CELL SPECIFICITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOSE RESPONSE; FLOW RATE; GLIOMA; HISTOPATHOLOGY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; TISSUE INJURY; TUMOR LOCALIZATION;

AMINOLEVULINIC ACID; ANIMALS; BLOOD-BRAIN BARRIER; MAGNETIC RESONANCE IMAGING; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RATS; RATS, INBRED F344;

EID: 53249113443     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20670     Document Type: Article

References (33)

1. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989;16:1405-1409.
2. Kroll RA, Neuwelt EA. Outwitting the blood-brain barrier for therapeutic purposes: Osmotic opening and other means. Neurosurgery 1998;42:1083-1099.
3. Siegal T, Zylber-Katz E. Strategies for increasing drug delivery to the brain. Clin Pharmacokinet 2002;41:171-186.
4. Groothuis DR, Fischer JM, Vick NA, Bigner DD. Comparative permeability of different glioma models to horseradish peroxidase. Cancer Treat Rep 1981;65:13-18.
5. Angell-Petersen E, Madsen SJ, Spetalen S, Sun C-H, Peng Q, Carper SW, Hirschberg H. Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. J Neurosurg 2006;104(1):109-117.
6. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Review: Photodynamic therapy. J Nat Can Inst 1998;90:889-905.
7. Cheng MS, McKean J, Boisvert D. Photoradiation therapy: Current status applications in the treatment of brain tumours. Surg Neurol 1986;25:423-435.
8. Muller PJ, Wilson BC, Lilge LD, Yang V, Hetzel FW, Chen Q, Selker R, Abrams J. Photofrin photodynamic therapy for malignant brain tumors. Proc SPIE 2001;4248:34-41.
9. Eljamel MS, Goodman C, Moseley H. ALA and Photofrin® Fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: A single centre Phase III randomized controlled trial. Lasers Med Sci 2007 Oct 10 [epub ahead of print].
10. Madsen SJ, Sun C-H, Tromberg BJ, Hirschberg H. Repetitive ALA-mediated photodynamic therapy on human glioma spheroids. J Neurooncol 2003;62:243-250.
11. Hirschberg H, Angell-Petersen E, Peng Q, Tromberg B, Sun CH, Madsen SJ. Repetitive photodynamic therapy of malignant brain tumors. J Environ Pathol Toxicol Oncol 2006;25(1-2):261-280.
12. Stummer W, Goetz C, Hassan A, Heimann DVM, Kempski O. Kinetics of Photofrin II in perifocal brain edema. Neurosurgery 1993;33:1075-1082.
13. Hebeda KM, Saarnak AE, Olivo M. 5-Aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumours and in the normal rat brain. Acta Neurochir 1998;140:503-513.
14. Hirschberg H, Mathews MS, Angell-Petersen E, Spetalen S, Madsen SJ. Increased brain edema following 5-aminolevulinic acid administration mediated photodynamic therapy in normal and tumor-bearing rats. Proc SPIE 2007;6424:64242B1-64242B8.
15. Itol S, Rachinger W, Stepp H, Reulen HJ, Stummer W. Oedema formation in experimental photo-irradiation therapy of brain tumours using 5-ALA. Acta Neurochir (Wien) 2005;147:57-65.
16. Giese A, Loo MA, Tran N, Haskett D, Coons SW, Berens ME. Dichotomy of astrocytoma migration and proliferation. Int J Cancer 1996;67:275-282.
17. Jolliet-Riant P, Tillementi J-P. Drug transfer across the blood-brain barrier and improvement of brain delivery. Fund Clin Pharmacol 1999;13:16-26.
18. Pardridge WM. Blood-brain barrier drug targeting: The future of brain drug development. Mol Interv 2003;3(2):90-105.
19. Doolittle ND, Miner ME, Hall WA, Siegal T, Jerome E, Osztie E, McAllister LD, Bubalo JS, Kraemer DF, Fortin D, Nixon R, Muldoon LL, Neuwelt EA. Safety and efficacy of a multicenter study using intra-arterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer 2000;88(3):637-647.
20. Rand RW, Kreitman RJ, Patronas N, Varricchio F, Pastan I, Puri RK. Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma. Clin Cancer Res 2000;6(6):2157-2165.
21. Sampson JH, Akabani G, Archer GE, Bigner DD, Berger MS, Friedman AH, Friedman HS, Herndon JE, Kunwar S, Marcus S, McLendon RE, Paolino A, Penne K, Provenzale J, Quinn J, Reardon DA, Rich J, Stenzel T, Tourt-Uhlig S, Wikstrand C, Wong T, Williams R, Yuan F, Zalutsky MR, Pastan I. Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors. J Neurooncol 2003;65(1):27-35.
22. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci 1994;91:2076-2080.
23. Lieberman DM, Laske DW, Morrison PF, Bankiewicz KS, Oldfield EH. Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J Neurosurg 1995;82:1021-1029.
24. Lidar Z, Mardor Y, Jonas T, Pfeffer R, Faibel M, Hadani M, Ram Z. Convection-enhanced delivery of paclitaxel for the treatment of recurrent glioblastoma. A phase I/II clinical study. J Neurosurg 2004;100:472-479.
25. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black KL, Sisti M, Brem S, Mohr G, Muller P, Morawetz R, Schold SC. For the Polymer-Brain Tumor Treatment Group: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 1995;345(8956):1008-1012.
26. Lawson HC, Sampath P, Bohan E, Park MC, Hussain N, Olivi A, Weingart J, Kleinberg L, Brem H. Interstitial chemotherapy for malignant gliomas: The Johns Hopkins experience. J Neurooncol 2007;83(1):61-70.
27. Choi JJ, Pernot M, Small SA, Konofagou EE. Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice. Ultrasound Med Biol 2007;33(1):95-104.
28. Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 2007;121:901-907.
29. Sporn LA, Foster TH. Photofrin and light induces microtubule depolymerization in cultured human endothelial cells. Cancer Res 1992;52:3443-3448.
30. Fingar VH. Vascular effects of photodynamic therapy. J Clin Laser Med Surg 1996;14:323-328.
31. Snyder JW, Greco WR, Bellnier DA, Vaughan L, Henderson BW. Photodynamic therapy: A means to enhanced drug delivery to tumors. Cancer Res 2003;63:8126-8131.
32. Hu SS, Cheng HB, Zheng YR, Zhang RY, Yue W, Zhang H. Effects of photodynamic therapy on the ultrastructure of glioma cells. Biomed Environ Sci 2007;20(4):269-273.
33. Madsen SJ, Sun C-H, Tromberg BJ, Hirschberg H. Development of a novel balloon applicator for optimizing light delivery in photodynamic therapy. Lasers Surg Med 2001;29:406-412.